SlideShare a Scribd company logo
1 of 24
Download to read offline
Revisiting the role of
immune privilege (IP)
in alopecia areata (AA) pathobiology
Ralf Paus
University of Manchester, Manchester, UK
No relevant conflicts of interest
Alopecia areata (AA)
= Hair follicle (HF) cycling disorder
Perifollicular inflammatory infiltrates
1. Attack only anagen hair bulb
(anagen III-VI)
2. Catapult anagen HFs
prematurely into catagen
3. Central role of MHC class I-based
HF immune privilege (IP)
collapse, CD8+ T cells & IFNg
ā€žNo IP collapse, no AAā€œ
ļƒ  HF damage (dystrophy),
hair shaft breakage & shedding:
Hair loss
V Price
WCHR, Miami, Nov 2015: AA pathobiology
ā€¢ Several different pathobiology pathways lead to AA,
which all coalesce in a stereotypic HF damage response,
the AA phenotype
ā€¢ This AA response pattern also occurs in healthy HFs
in individuals not genetically predisposed to AA
Most essential prerequisite:
ā€¢ Immune privilege (IP) collapse of anagen HFs
ā€¢ AA = ā€žterritorial diseaseā€œ ļƒ  pathobiology can only be deciphered
by intracutaneous analyses focused on IP collapse & restoration
Physiological status:
Immune privilege (IP) of anagen HF
No MHC I
No Ɵ2mg / TAP:
ā€¢ No autoantigen
presentation
TGFƟ1/2, aMSH
cortisol, MIF:
ā€¢ ā€žIP guardiansā€œ
create immuno-
inhibitory milieu
Main IP pillars:
Ito T et al. AJP 2004
Billingham & Silvers JID 1971
Westgate et al. JID 1991
Paus et al. Yale J Biol Med 1993
Physiological status:
Immune privilege (IP) of anagen HF
No MHC I
No Ɵ2mg / TAP:
ā€¢ No autoantigen
presentation
TGFƟ1/2, aMSH
cortisol, MIF:
ā€¢ ā€žIP guardiansā€œ
create immuno-
inhibitory milieu
No MHC class II+ LCs:
antigen-presentation
to CD4+ TCs impaired
Christoph et al. BJD 2000
Low level of NKG2D ligands
(MICA, ULBP3):
Insufficient stimulation of
NKG2D+ cells
(NKs, NKTs, CD8)
Ito T et al. JID 2008
Petukhova et al. Nature 2010
Main IP pillars:
Ito T et al. AJP 2004
Billingham & Silvers JID 1971
Westgate et al. JID 1991
Paus et al. Yale J Biol Med 1993
Frontiers in HF immune privilege
No MHC I
No Ɵ2mg / TAP:
ā€¢ No autoantigen
presentation
TGFƟ1/2, aMSH, IGF-1,
SST, cortisol, MIF,
CGRP, PD-L1, VIP :
ā€žIP guardiansā€œ
create immuno-
inhibitory milieu
No MHC class II+ LCs:
antigen-presentation
to CD4+ TCs impaired
Low level of NKG2D ligands
(MICA, ULBP3):
Insufficient stimulation of
NKG2D+ cells
(NKs, NKTs, CD8)
Immunoinhibitory
function of peri-
follicular mast cells
in HF physiology
Bertolini et al. PLoS ONE 2014
Kinori etal. EXD 2012, Breitkopf et al. JID 2013, Wang et al. JID 2014, Bertolini et al. BJD 2016
Role of mast cells (MCs) in AA ?
ļƒ 
Lesional AA skin:
ā€¢ much more &
hyperproliferating MCs
ā€¢ more direct interatcions
between MCs & CD8+ TCs
Compared to non-lesional AA skin &
to healthy human scalp skin
Pink cells= MCs, Brown cells= CD8+ T-cells
Bertolini et al. PLoS ONE 2014
Collab.: K McElwee, A Gilhar et al.
MCs in healthy perifollicular
human scalp skin
MCs in lesional AA skin
Perifollicular MCs switch from an immuno-inhibitory
to a pro-inflammatory phenotype in lesional AA skin
MHCI
Heparin-
Histamine
c-Kit
PD-L1
OX40L
TGFĪ²-1
Tryptase
IL-10
CD30L
Mast Cell
4-1BBL
ICAM-1
c-Kit
MHCI
Heparin-
Histamine
4-1BBL
OX40L
PD-L1
IL-10
TGFĪ²-1
Tryptase
CD30L
Mast Cell
Ag?ICAM-1
Bertolini et al.
PLoS ONE 2014
ļƒ  Does this MCs switch promote & maintain IP collapse ?
ļƒ  Do these MCs regulate (auto-)antigen specific CD8+ T cells in AA ?
Mice: possible in principle ļƒ  Stelekati/Paus/Bulfone-Paus et al. Immunity 2009
IP guardians up
IP guardians down
Profinflammatory signals up
Frontiers in HF immune privilege
No MHC I
No Ɵ2mg / TAP:
ā€¢ No autoantigen
presentation
TGFƟ1/2, aMSH, IGF-1,
SST, cortisol, MIF,
CGRP, PD-L1, VIP :
ā€¢ ā€žIP guardiansā€œ
create immuno-
inhibitory milieu
No MHC class II+ LCs:
antigen-presentation
to CD4+ TCs impaired
Low level of NKG2D ligands
(MICA, ULBP3):
Insufficient stimulation of
NKG2D+ cells
(NKs, NKTs, CD8, gdTCs)
ļƒ  Y Uchida / M Bertolini
immunoinhibitory function
perifollicular mast cellsPeripheral tolerance
to anagen HF-associated
(auto-)antigens
Role of Tregs ?
ļƒ  M Rosenblum
Oelert et al Exp Dermatol 2016
AIRE gene ?
Kumar et al. AJP 2011:
HF co-local isation with K17
ļƒ  Multiple factors promote IP collapse in AA
MHC I, Ɵ2mg, TAP :
(Auto-)antigen
presentation
TGFƟ1/2, aMSH, IGF-1
Cortisol, VIP-R, MIF :
Autoimmmunity-
promoting milieu
Mast cells
switch to
Proinflammatory
phenotype
Promotion of
autoantigen-specific
CD8+ T cells responses ?
Key role of excessive
IFNg signaling via JAK
IFNg-inducible chemokines
e.g. CXCL10, CXCR3
Ito T et al. JDS 2013; Dai et al JI 2016
Xing et al. Nat Med 2014
ļƒ  Multiple factors promote IP collapse in AA
MHC I, Ɵ2mg, TAP :
(Auto-)antigen
presentation
TGFƟ1/2, aMSH, IGF-1
Cortisol, VIP-R, MIF :
Autoimmmunity-
promoting milieu
Mast cells switch to
Proinflammatory phenotype
Promotion of autoantigen-specific
CD8+ T cells responses ?
Key role of excessive
IFNg signaling via JAK
Loss of peripheral tolerance
to HF (auto-)antigens
IFNg-inducible chemokines
e.g. CXCL10, CXCR3
Ito T et al. JDS 2013; Dai et al JI 2016
Xing et al. Nat Med 2014
Perceived stress &
neurogenic inflammation:
SP, mast cells
Peters et al. AJP 2007 (human)
Siebenhaar et al. JID 2007 (mice)
MHC II :
Secondary autoimmune responses
epitope spreading ?
ļƒ  Multiple factors promote IP collapse in AA
MHC I, Ɵ2mg, TAP :
(Auto-)antigen
presentation
TGFƟ1/2, aMSH, IGF-1
Cortisol, VIP-R, MIF :
Autoimmmunity-
promoting milieu
MHC II :
Secondary autoimmune
responses epitope spreading ?
ā€žstressedā€œ HFs:
NKG2D ligands
MICA, (ULBP3): Li/Sinclair et al. JID 2016
Activation of
NKG2D+ cells
NKs, CD8+ TCs, gdTCs
Mast cells switch to
proinflammatory phenotype
Key role of excessive
IFNg signaling via JAK
Loss of peripheral tolerance
to HF (auto-)antigens
AA
IFNg-inducible chemokines
e.g. CXCL10, CXCR3
AIRE SNPs ?
Wengraf/Tazi-Ahnini 2008
Treg defect ?
Perceived stress &
neurogenic inflammation:
SP, mast cells
gd T-cells and HF biology
ā€¢ gd T-cell number fluctuates significantly during murine hair cycle
Paus et al. BJD 1994 + JID 1998
ā€¢ Only extremely few gd T-cells in/around human HFs
Christoph et al. BJD 2000
ā€¢ gd TC KO mice show catagen retardation, followed by acceleration
of HF cycling Klƶpper et al. JID 2013
ā€¢ FGF9-secreting gd T-cells: key role in wounding-induced HF
neogenesisis Gay/Cotsarelis et al. 2013
ā€¢ gd T-cells are involved in stress surveilance in murine skin
Hayday, 2009
HYPOTHESIS:
Can excessive stress immunosurveillance activities of
gd T-cells induce HF IP collapse and
thus contribute to AA pathogenesis ?
N=15-21 HFs/group from 6-7 AA patients or healthy donors.
Vd1+T-cells infiltrate in /around AA hair bulbs
A
HS = healthy skin
NL = non-lesional AA skin
AA = lesional AA skin
ā€¦ also seen in
experimentally induced
AA in human skin
xenotransplants in vivo
(Gilharā€˜s humanized
AA mouse model)
Youhei Uchida et al
unpublished
Vd1+T-cells show increased NKG2D
& IFNg expression within AA lesions
E
ļƒ Do Vd1+T cells operate as
stress sentinels around human HFs ?
NKG2D IFNg
HS = healthy skin, NL = non-lesional AA skin
AA = lesional AA skin
Ki67/TUNEL
staining
ā€¢ Reduced hair matrix
& outer root sheath
KC proliferation
ā€¢ Massive outer root
sheath KC apoptosis
ā€¢ Signs of direct HF
cytotoxicity
incl.
enhanced LDH release
loss of intercellular adhesion
pigmentary abnormalities
(e.g. melanin clumping)
Co-culture of ā€œstressedā€ scalp HFs with autologous
dermal Vd1+T-cells induces HF dystrophy ex vivo
Autologous dermal Vd1+T-cells induce HF IP collapse
and premature catagen in ā€œstressedā€ HFs
ā€¢ ā†‘ MHC class I; ā†‘ MICA
ā€¢ ā†“ IP guardians: Ī±MSH and TGFƟ2 = AA phenocopy !
ā€¢ premature catagen, HF dystrophy
MHC class I Ī±MSH TGFĪ²2
Hair cycle
Autologous dermal Vd1+T-cells become activated and
up-regulate IFNg and NKG2D when co-cultured with
ā€œstressedā€ human scalp HFs
Isotype control; non-co-cultured Vd1 T cells
Vd1 T cells co-cultured with ā€œstressedā€, healthy (non-AA) scalp HFs
n= 3 experiments from 3 donors
ļƒ None of the above phenomena seen with
ā€žnon-stressedā€œ human scalp HFs
ļƒ Abrogated by anti- IFNg, CD1d or MICA antibodies
Conclusions 1
ā€¢ New physiological role of human gd T cells (Vd1)
in human skin biology:
ļƒ  scouting for
distress signals
from "stressed" HFs
Conclusions 2
ā€¢ These physiological stress sentinel functions of dermal Vd1 T cells
can become pathological by inducing IP collapse & promoting AA
AA
response
pattern
Youhei Uchida
Marta Bertolini
Jennifer Gherardini
JƩrƩmy ChƩret
et al.
Special thanks to:
Amos Gilhar, Haifa
Alfredo Rossi, Rome
Acknowledgements
gd TC study
Kagoshima Univ
Japan
Jeremy Jen
ā€¢ Therapeutically, protecting & restoring HF IP is crucial
& has the widest success chance among AA therapies
ļƒ  works in all AA pathobiology scenarios, but is not curative
ā€¢ Antagonizing IFNg/JAK signalling makes perfect sense, but is
not the only sensible strategy & is also not curative
ā€¢ Identifying the elusive CD8+/MHC class I-presented (auto-)
antigens in AA and restoring peripheral tolerance
remains critical for curative AA therapy
ā€¢ Yet, this strategy will counteract only one of several IP collapse
pathways leading to the AA response pattern
ļƒ  understand roles of Tregs, NKTregs, chemokines, AIRE in human AA
ļƒ target also mast cells, NK cells, excessive gdTCs activities
ļƒ restore IP guardians (aMSH, VIP, CGRP; antagonize SP)
Multimodal AA therapy needed !
T cell "induced-self" MHC class I/peptide complexes may enable "de
novo" tolerance induction to neo-antigens outside of the thymus
Oelert T, Gilhar A, Paus R. Exp Dermatol. 2016 Oct [Epub ahead of print]
HF epithelium can present self-antigens to cognate CD8+ T cells,
incl. hair cycle-dependent immunogenic proteins including HF-specific neo-antigens.
HYPOTHESIS:
IFNg derived from antigen-specific T cells spotting self-peptides may induce
& alter self-antigen presentation ("induced-self").
Initially, this silences autoreactive T cells, including neo-epitope-specific T cells.
Since the thymus cannot recapitulate neo-epitopes evolving in the periphery,
HF-specific induction of MHC molecules that present these neo-epitopes to
self-peptide-reactive CD8+ T cells is a key element of self-tolerance.
Subsequently, however, the local perpetuation and modification of this crosstalk
induces HF IP collapse and AA
ļƒ  complements thymus-based regulation models of self/non-self-discrimination:
ļƒ  "induced-self" in HF maintains peripheral self-tolerance in the case of "danger"
ļƒ  Can backfire, leading to AA

More Related Content

What's hot

Autoimmune disorders
Autoimmune disordersAutoimmune disorders
Autoimmune disorders
Vamsi Chakradhar
Ā 
Autoimmune disorders
Autoimmune disordersAutoimmune disorders
Autoimmune disorders
vinonamu
Ā 
14 Primary Immunodeficiency Diseases
14 Primary Immunodeficiency  Diseases14 Primary Immunodeficiency  Diseases
14 Primary Immunodeficiency Diseases
ghalan
Ā 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
Riyaz Sheriff
Ā 

What's hot (20)

Monoclonal and Polyclonal antibodies
Monoclonal and Polyclonal antibodiesMonoclonal and Polyclonal antibodies
Monoclonal and Polyclonal antibodies
Ā 
TRANSPLANT IMMUNOLOGY
TRANSPLANT IMMUNOLOGYTRANSPLANT IMMUNOLOGY
TRANSPLANT IMMUNOLOGY
Ā 
Auto immune diseases
Auto immune diseasesAuto immune diseases
Auto immune diseases
Ā 
Steps in immune response
Steps in immune responseSteps in immune response
Steps in immune response
Ā 
Autoimmune disorders
Autoimmune disordersAutoimmune disorders
Autoimmune disorders
Ā 
Biological Treatment of Atopic Dermatitis
Biological Treatment of Atopic DermatitisBiological Treatment of Atopic Dermatitis
Biological Treatment of Atopic Dermatitis
Ā 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
Ā 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency Syndrome
Ā 
Autoimmune diseases
Autoimmune diseasesAutoimmune diseases
Autoimmune diseases
Ā 
Mast cell activation syndrome.pdf
Mast cell activation syndrome.pdfMast cell activation syndrome.pdf
Mast cell activation syndrome.pdf
Ā 
OVERVIEW OF NORMAL IMMUNE SYSTEM
OVERVIEW OF NORMAL IMMUNE SYSTEMOVERVIEW OF NORMAL IMMUNE SYSTEM
OVERVIEW OF NORMAL IMMUNE SYSTEM
Ā 
Autoimmune disorders
Autoimmune disordersAutoimmune disorders
Autoimmune disorders
Ā 
immunology chapter 9 : activation of T lymphocytes
immunology chapter 9 : activation of T lymphocytesimmunology chapter 9 : activation of T lymphocytes
immunology chapter 9 : activation of T lymphocytes
Ā 
Autoimmune disorders
Autoimmune disordersAutoimmune disorders
Autoimmune disorders
Ā 
Tolerance Auto-immune Diseases and Tumor Immunity
Tolerance Auto-immune Diseases and Tumor ImmunityTolerance Auto-immune Diseases and Tumor Immunity
Tolerance Auto-immune Diseases and Tumor Immunity
Ā 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
Ā 
Secondary immunodeficiency
Secondary immunodeficiencySecondary immunodeficiency
Secondary immunodeficiency
Ā 
14 Primary Immunodeficiency Diseases
14 Primary Immunodeficiency  Diseases14 Primary Immunodeficiency  Diseases
14 Primary Immunodeficiency Diseases
Ā 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
Ā 
Everything you need to know about alopecia areata
Everything you need to know about alopecia areataEverything you need to know about alopecia areata
Everything you need to know about alopecia areata
Ā 

Viewers also liked

Histopathology of alopecia
Histopathology of alopeciaHistopathology of alopecia
Histopathology of alopecia
Mohammad Manzoor
Ā 
Epic presentation
Epic presentationEpic presentation
Epic presentation
pshaw0682
Ā 

Viewers also liked (14)

You Tube
You TubeYou Tube
You Tube
Ā 
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
Ā 
Building an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AABuilding an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AA
Ā 
Similarities between Type 1 Diabetes and Alopecia Areata
Similarities between Type 1 Diabetes and Alopecia AreataSimilarities between Type 1 Diabetes and Alopecia Areata
Similarities between Type 1 Diabetes and Alopecia Areata
Ā 
Prevalence of Alopecia Areata Differs by Race in Two Large Cohorts
Prevalence of Alopecia Areata Differs by Race in Two Large CohortsPrevalence of Alopecia Areata Differs by Race in Two Large Cohorts
Prevalence of Alopecia Areata Differs by Race in Two Large Cohorts
Ā 
Orphan Drug Designation
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
Ā 
Repurposing Drugs for Alopecia Areata: The Vytorin Experience
Repurposing Drugs for Alopecia Areata: The Vytorin ExperienceRepurposing Drugs for Alopecia Areata: The Vytorin Experience
Repurposing Drugs for Alopecia Areata: The Vytorin Experience
Ā 
Histopathology of alopecia
Histopathology of alopeciaHistopathology of alopecia
Histopathology of alopecia
Ā 
PCORI: Engaging Patients in Clinical Trials & Outcomes Research
PCORI: Engaging Patients in Clinical Trials & Outcomes ResearchPCORI: Engaging Patients in Clinical Trials & Outcomes Research
PCORI: Engaging Patients in Clinical Trials & Outcomes Research
Ā 
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
Ā 
Epic presentation
Epic presentationEpic presentation
Epic presentation
Ā 
Epic Workflow Optimization Project for Cadence Prelude
Epic Workflow Optimization Project for Cadence PreludeEpic Workflow Optimization Project for Cadence Prelude
Epic Workflow Optimization Project for Cadence Prelude
Ā 
Understanding Parallels between Vitiligo and Alopecia Areata
Understanding Parallels between Vitiligo and Alopecia AreataUnderstanding Parallels between Vitiligo and Alopecia Areata
Understanding Parallels between Vitiligo and Alopecia Areata
Ā 
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
Ā 

Similar to Revisiting the Role of Immune Privilege in Alopecia Areata Pathobiology

J Immunol-2008-Pulecio-1135-42
J Immunol-2008-Pulecio-1135-42J Immunol-2008-Pulecio-1135-42
J Immunol-2008-Pulecio-1135-42
Federica Benvenuti
Ā 
Anticancer immunity 2013
Anticancer immunity 2013Anticancer immunity 2013
Anticancer immunity 2013
Elsa von Licy
Ā 
ETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatologyETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatology
Derma202
Ā 
May r.j.-et-al.-2007-clinical-cancer-research
May r.j.-et-al.-2007-clinical-cancer-researchMay r.j.-et-al.-2007-clinical-cancer-research
May r.j.-et-al.-2007-clinical-cancer-research
SellasCorp
Ā 
En docrine changes with immune therapy1
En docrine changes with immune therapy1En docrine changes with immune therapy1
En docrine changes with immune therapy1
Rajasree nambron
Ā 

Similar to Revisiting the Role of Immune Privilege in Alopecia Areata Pathobiology (20)

Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Ā 
Pros and Cons of the C3H HeJ versus the Humanized Mouse Model
Pros and Cons of the C3H HeJ versus the Humanized Mouse ModelPros and Cons of the C3H HeJ versus the Humanized Mouse Model
Pros and Cons of the C3H HeJ versus the Humanized Mouse Model
Ā 
Dpp4 i for the treatment of ACNE
Dpp4 i for the treatment of ACNEDpp4 i for the treatment of ACNE
Dpp4 i for the treatment of ACNE
Ā 
Who are at risk for mycobacterial infections
Who are at risk for mycobacterial infectionsWho are at risk for mycobacterial infections
Who are at risk for mycobacterial infections
Ā 
J Immunol-2008-Pulecio-1135-42
J Immunol-2008-Pulecio-1135-42J Immunol-2008-Pulecio-1135-42
J Immunol-2008-Pulecio-1135-42
Ā 
Anticancer immunity 2013
Anticancer immunity 2013Anticancer immunity 2013
Anticancer immunity 2013
Ā 
ETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatologyETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatology
Ā 
Combined Immunodeficiency
Combined ImmunodeficiencyCombined Immunodeficiency
Combined Immunodeficiency
Ā 
Interferon-gamma and immune system
Interferon-gamma and immune systemInterferon-gamma and immune system
Interferon-gamma and immune system
Ā 
May r.j.-et-al.-2007-clinical-cancer-research
May r.j.-et-al.-2007-clinical-cancer-researchMay r.j.-et-al.-2007-clinical-cancer-research
May r.j.-et-al.-2007-clinical-cancer-research
Ā 
Autophagy
Autophagy  Autophagy
Autophagy
Ā 
Autophagy nirmal
Autophagy  nirmalAutophagy  nirmal
Autophagy nirmal
Ā 
2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day
Ā 
En docrine changes with immune therapy1
En docrine changes with immune therapy1En docrine changes with immune therapy1
En docrine changes with immune therapy1
Ā 
Controversy: the role of immunomodulator in allergic case
Controversy: the role of immunomodulator in allergic caseControversy: the role of immunomodulator in allergic case
Controversy: the role of immunomodulator in allergic case
Ā 
IDO pathway from bench to clinic
IDO pathway from bench to clinicIDO pathway from bench to clinic
IDO pathway from bench to clinic
Ā 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
Ā 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
Ā 
2015 11 Inmunoterapia en nsclc
2015 11 Inmunoterapia en nsclc2015 11 Inmunoterapia en nsclc
2015 11 Inmunoterapia en nsclc
Ā 
CD25
CD25CD25
CD25
Ā 

More from National Alopecia Areata Foundation

More from National Alopecia Areata Foundation (20)

What's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia AreataWhat's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia Areata
Ā 
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and EducationPediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
Ā 
Treatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: OverviewTreatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: Overview
Ā 
NAAF Scientific Update
NAAF Scientific UpdateNAAF Scientific Update
NAAF Scientific Update
Ā 
Translating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatricsTranslating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatrics
Ā 
Therapeutic advances in alopecia areata
Therapeutic advances in alopecia areataTherapeutic advances in alopecia areata
Therapeutic advances in alopecia areata
Ā 
The therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitisThe therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitis
Ā 
Epidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areataEpidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areata
Ā 
The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areata
Ā 
Genetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout ReportGenetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout Report
Ā 
Health Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout ReportHealth Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout Report
Ā 
Clinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout ReportClinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout Report
Ā 
Broadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsBroadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial Participants
Ā 
Willingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia AreataWillingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia Areata
Ā 
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata EtiologyRare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
Ā 
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
Ā 
The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...
Ā 
NAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes ConsortiumNAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes Consortium
Ā 
Standardizing Outcome Measures in Alopecia Areata
Standardizing Outcome Measures in Alopecia AreataStandardizing Outcome Measures in Alopecia Areata
Standardizing Outcome Measures in Alopecia Areata
Ā 
Legacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program OverviewLegacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program Overview
Ā 

Recently uploaded

Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...
amritaverma53
Ā 
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan 087776558899
Ā 
šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...
šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...
šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...
rajnisinghkjn
Ā 
ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...
ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...
ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...
Rashmi Entertainment
Ā 

Recently uploaded (20)

šŸ’°Call Girl In Bangaloreā˜Žļø63788-78445šŸ’° Call Girl service in Bangaloreā˜ŽļøBangalo...
šŸ’°Call Girl In Bangaloreā˜Žļø63788-78445šŸ’° Call Girl service in Bangaloreā˜ŽļøBangalo...šŸ’°Call Girl In Bangaloreā˜Žļø63788-78445šŸ’° Call Girl service in Bangaloreā˜ŽļøBangalo...
šŸ’°Call Girl In Bangaloreā˜Žļø63788-78445šŸ’° Call Girl service in Bangaloreā˜ŽļøBangalo...
Ā 
(RIYA)šŸŽ„Airhostess Call Girl Jaipur Call Now 8445551418 Premium Collection Of ...
(RIYA)šŸŽ„Airhostess Call Girl Jaipur Call Now 8445551418 Premium Collection Of ...(RIYA)šŸŽ„Airhostess Call Girl Jaipur Call Now 8445551418 Premium Collection Of ...
(RIYA)šŸŽ„Airhostess Call Girl Jaipur Call Now 8445551418 Premium Collection Of ...
Ā 
Chennai ā£ļø Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ā£ļø Call Girl 6378878445 Call Girls in Chennai Escort service book nowChennai ā£ļø Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ā£ļø Call Girl 6378878445 Call Girls in Chennai Escort service book now
Ā 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
Ā 
šŸ’ž Safe And Secure Call Girls CoimbatorešŸ§æ 6378878445 šŸ§æ High Class Coimbatore C...
šŸ’ž Safe And Secure Call Girls CoimbatorešŸ§æ 6378878445 šŸ§æ High Class Coimbatore C...šŸ’ž Safe And Secure Call Girls CoimbatorešŸ§æ 6378878445 šŸ§æ High Class Coimbatore C...
šŸ’ž Safe And Secure Call Girls CoimbatorešŸ§æ 6378878445 šŸ§æ High Class Coimbatore C...
Ā 
Call Girls in Lucknow Just Call šŸ‘‰šŸ‘‰ 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call šŸ‘‰šŸ‘‰ 8875999948 Top Class Call Girl Service Ava...Call Girls in Lucknow Just Call šŸ‘‰šŸ‘‰ 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call šŸ‘‰šŸ‘‰ 8875999948 Top Class Call Girl Service Ava...
Ā 
Call Girls Bangalore - 450+ Call Girl Cash Payment šŸ’ÆCall Us šŸ” 6378878445 šŸ” šŸ’ƒ ...
Call Girls Bangalore - 450+ Call Girl Cash Payment šŸ’ÆCall Us šŸ” 6378878445 šŸ” šŸ’ƒ ...Call Girls Bangalore - 450+ Call Girl Cash Payment šŸ’ÆCall Us šŸ” 6378878445 šŸ” šŸ’ƒ ...
Call Girls Bangalore - 450+ Call Girl Cash Payment šŸ’ÆCall Us šŸ” 6378878445 šŸ” šŸ’ƒ ...
Ā 
Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No šŸ“ž 7427069034 šŸ“ž VIP Escorts Service Availab...
Ā 
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Ā 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
Ā 
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Ā 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
Ā 
šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...
šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...
šŸ‘‰ Chennai Sexy Auntyā€™s WhatsApp Number šŸ‘‰šŸ“ž 7427069034 šŸ‘‰šŸ“ž JustšŸ“² Call Ruhi Colle...
Ā 
Call 8250092165 Patna Call Girls ā‚¹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ā‚¹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ā‚¹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ā‚¹4.5k Cash Payment With Room Delivery
Ā 
Bhawanipatna Call Girls šŸ“ž9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls šŸ“ž9332606886 Call Girls in Bhawanipatna Escorts servic...Bhawanipatna Call Girls šŸ“ž9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls šŸ“ž9332606886 Call Girls in Bhawanipatna Escorts servic...
Ā 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Ā 
ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...
ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...
ā¤ļø Chandigarh Call Girlsā˜Žļø98151-579OOā˜Žļø Call Girl service in Chandigarh ā˜Žļø Ch...
Ā 
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableCall Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Ā 
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
Ā 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
Ā 

Revisiting the Role of Immune Privilege in Alopecia Areata Pathobiology

  • 1. Revisiting the role of immune privilege (IP) in alopecia areata (AA) pathobiology Ralf Paus University of Manchester, Manchester, UK No relevant conflicts of interest
  • 2. Alopecia areata (AA) = Hair follicle (HF) cycling disorder Perifollicular inflammatory infiltrates 1. Attack only anagen hair bulb (anagen III-VI) 2. Catapult anagen HFs prematurely into catagen 3. Central role of MHC class I-based HF immune privilege (IP) collapse, CD8+ T cells & IFNg ā€žNo IP collapse, no AAā€œ ļƒ  HF damage (dystrophy), hair shaft breakage & shedding: Hair loss V Price
  • 3. WCHR, Miami, Nov 2015: AA pathobiology ā€¢ Several different pathobiology pathways lead to AA, which all coalesce in a stereotypic HF damage response, the AA phenotype ā€¢ This AA response pattern also occurs in healthy HFs in individuals not genetically predisposed to AA Most essential prerequisite: ā€¢ Immune privilege (IP) collapse of anagen HFs ā€¢ AA = ā€žterritorial diseaseā€œ ļƒ  pathobiology can only be deciphered by intracutaneous analyses focused on IP collapse & restoration
  • 4. Physiological status: Immune privilege (IP) of anagen HF No MHC I No Ɵ2mg / TAP: ā€¢ No autoantigen presentation TGFƟ1/2, aMSH cortisol, MIF: ā€¢ ā€žIP guardiansā€œ create immuno- inhibitory milieu Main IP pillars: Ito T et al. AJP 2004 Billingham & Silvers JID 1971 Westgate et al. JID 1991 Paus et al. Yale J Biol Med 1993
  • 5. Physiological status: Immune privilege (IP) of anagen HF No MHC I No Ɵ2mg / TAP: ā€¢ No autoantigen presentation TGFƟ1/2, aMSH cortisol, MIF: ā€¢ ā€žIP guardiansā€œ create immuno- inhibitory milieu No MHC class II+ LCs: antigen-presentation to CD4+ TCs impaired Christoph et al. BJD 2000 Low level of NKG2D ligands (MICA, ULBP3): Insufficient stimulation of NKG2D+ cells (NKs, NKTs, CD8) Ito T et al. JID 2008 Petukhova et al. Nature 2010 Main IP pillars: Ito T et al. AJP 2004 Billingham & Silvers JID 1971 Westgate et al. JID 1991 Paus et al. Yale J Biol Med 1993
  • 6. Frontiers in HF immune privilege No MHC I No Ɵ2mg / TAP: ā€¢ No autoantigen presentation TGFƟ1/2, aMSH, IGF-1, SST, cortisol, MIF, CGRP, PD-L1, VIP : ā€žIP guardiansā€œ create immuno- inhibitory milieu No MHC class II+ LCs: antigen-presentation to CD4+ TCs impaired Low level of NKG2D ligands (MICA, ULBP3): Insufficient stimulation of NKG2D+ cells (NKs, NKTs, CD8) Immunoinhibitory function of peri- follicular mast cells in HF physiology Bertolini et al. PLoS ONE 2014 Kinori etal. EXD 2012, Breitkopf et al. JID 2013, Wang et al. JID 2014, Bertolini et al. BJD 2016
  • 7. Role of mast cells (MCs) in AA ? ļƒ  Lesional AA skin: ā€¢ much more & hyperproliferating MCs ā€¢ more direct interatcions between MCs & CD8+ TCs Compared to non-lesional AA skin & to healthy human scalp skin Pink cells= MCs, Brown cells= CD8+ T-cells Bertolini et al. PLoS ONE 2014 Collab.: K McElwee, A Gilhar et al.
  • 8. MCs in healthy perifollicular human scalp skin MCs in lesional AA skin Perifollicular MCs switch from an immuno-inhibitory to a pro-inflammatory phenotype in lesional AA skin MHCI Heparin- Histamine c-Kit PD-L1 OX40L TGFĪ²-1 Tryptase IL-10 CD30L Mast Cell 4-1BBL ICAM-1 c-Kit MHCI Heparin- Histamine 4-1BBL OX40L PD-L1 IL-10 TGFĪ²-1 Tryptase CD30L Mast Cell Ag?ICAM-1 Bertolini et al. PLoS ONE 2014 ļƒ  Does this MCs switch promote & maintain IP collapse ? ļƒ  Do these MCs regulate (auto-)antigen specific CD8+ T cells in AA ? Mice: possible in principle ļƒ  Stelekati/Paus/Bulfone-Paus et al. Immunity 2009 IP guardians up IP guardians down Profinflammatory signals up
  • 9. Frontiers in HF immune privilege No MHC I No Ɵ2mg / TAP: ā€¢ No autoantigen presentation TGFƟ1/2, aMSH, IGF-1, SST, cortisol, MIF, CGRP, PD-L1, VIP : ā€¢ ā€žIP guardiansā€œ create immuno- inhibitory milieu No MHC class II+ LCs: antigen-presentation to CD4+ TCs impaired Low level of NKG2D ligands (MICA, ULBP3): Insufficient stimulation of NKG2D+ cells (NKs, NKTs, CD8, gdTCs) ļƒ  Y Uchida / M Bertolini immunoinhibitory function perifollicular mast cellsPeripheral tolerance to anagen HF-associated (auto-)antigens Role of Tregs ? ļƒ  M Rosenblum Oelert et al Exp Dermatol 2016 AIRE gene ? Kumar et al. AJP 2011: HF co-local isation with K17
  • 10. ļƒ  Multiple factors promote IP collapse in AA MHC I, Ɵ2mg, TAP : (Auto-)antigen presentation TGFƟ1/2, aMSH, IGF-1 Cortisol, VIP-R, MIF : Autoimmmunity- promoting milieu Mast cells switch to Proinflammatory phenotype Promotion of autoantigen-specific CD8+ T cells responses ? Key role of excessive IFNg signaling via JAK IFNg-inducible chemokines e.g. CXCL10, CXCR3 Ito T et al. JDS 2013; Dai et al JI 2016 Xing et al. Nat Med 2014
  • 11. ļƒ  Multiple factors promote IP collapse in AA MHC I, Ɵ2mg, TAP : (Auto-)antigen presentation TGFƟ1/2, aMSH, IGF-1 Cortisol, VIP-R, MIF : Autoimmmunity- promoting milieu Mast cells switch to Proinflammatory phenotype Promotion of autoantigen-specific CD8+ T cells responses ? Key role of excessive IFNg signaling via JAK Loss of peripheral tolerance to HF (auto-)antigens IFNg-inducible chemokines e.g. CXCL10, CXCR3 Ito T et al. JDS 2013; Dai et al JI 2016 Xing et al. Nat Med 2014 Perceived stress & neurogenic inflammation: SP, mast cells Peters et al. AJP 2007 (human) Siebenhaar et al. JID 2007 (mice) MHC II : Secondary autoimmune responses epitope spreading ?
  • 12. ļƒ  Multiple factors promote IP collapse in AA MHC I, Ɵ2mg, TAP : (Auto-)antigen presentation TGFƟ1/2, aMSH, IGF-1 Cortisol, VIP-R, MIF : Autoimmmunity- promoting milieu MHC II : Secondary autoimmune responses epitope spreading ? ā€žstressedā€œ HFs: NKG2D ligands MICA, (ULBP3): Li/Sinclair et al. JID 2016 Activation of NKG2D+ cells NKs, CD8+ TCs, gdTCs Mast cells switch to proinflammatory phenotype Key role of excessive IFNg signaling via JAK Loss of peripheral tolerance to HF (auto-)antigens AA IFNg-inducible chemokines e.g. CXCL10, CXCR3 AIRE SNPs ? Wengraf/Tazi-Ahnini 2008 Treg defect ? Perceived stress & neurogenic inflammation: SP, mast cells
  • 13. gd T-cells and HF biology ā€¢ gd T-cell number fluctuates significantly during murine hair cycle Paus et al. BJD 1994 + JID 1998 ā€¢ Only extremely few gd T-cells in/around human HFs Christoph et al. BJD 2000 ā€¢ gd TC KO mice show catagen retardation, followed by acceleration of HF cycling Klƶpper et al. JID 2013 ā€¢ FGF9-secreting gd T-cells: key role in wounding-induced HF neogenesisis Gay/Cotsarelis et al. 2013 ā€¢ gd T-cells are involved in stress surveilance in murine skin Hayday, 2009 HYPOTHESIS: Can excessive stress immunosurveillance activities of gd T-cells induce HF IP collapse and thus contribute to AA pathogenesis ?
  • 14. N=15-21 HFs/group from 6-7 AA patients or healthy donors. Vd1+T-cells infiltrate in /around AA hair bulbs A HS = healthy skin NL = non-lesional AA skin AA = lesional AA skin ā€¦ also seen in experimentally induced AA in human skin xenotransplants in vivo (Gilharā€˜s humanized AA mouse model) Youhei Uchida et al unpublished
  • 15. Vd1+T-cells show increased NKG2D & IFNg expression within AA lesions E ļƒ Do Vd1+T cells operate as stress sentinels around human HFs ? NKG2D IFNg HS = healthy skin, NL = non-lesional AA skin AA = lesional AA skin
  • 16. Ki67/TUNEL staining ā€¢ Reduced hair matrix & outer root sheath KC proliferation ā€¢ Massive outer root sheath KC apoptosis ā€¢ Signs of direct HF cytotoxicity incl. enhanced LDH release loss of intercellular adhesion pigmentary abnormalities (e.g. melanin clumping) Co-culture of ā€œstressedā€ scalp HFs with autologous dermal Vd1+T-cells induces HF dystrophy ex vivo
  • 17. Autologous dermal Vd1+T-cells induce HF IP collapse and premature catagen in ā€œstressedā€ HFs ā€¢ ā†‘ MHC class I; ā†‘ MICA ā€¢ ā†“ IP guardians: Ī±MSH and TGFƟ2 = AA phenocopy ! ā€¢ premature catagen, HF dystrophy MHC class I Ī±MSH TGFĪ²2 Hair cycle
  • 18. Autologous dermal Vd1+T-cells become activated and up-regulate IFNg and NKG2D when co-cultured with ā€œstressedā€ human scalp HFs Isotype control; non-co-cultured Vd1 T cells Vd1 T cells co-cultured with ā€œstressedā€, healthy (non-AA) scalp HFs n= 3 experiments from 3 donors ļƒ None of the above phenomena seen with ā€žnon-stressedā€œ human scalp HFs ļƒ Abrogated by anti- IFNg, CD1d or MICA antibodies
  • 19. Conclusions 1 ā€¢ New physiological role of human gd T cells (Vd1) in human skin biology: ļƒ  scouting for distress signals from "stressed" HFs
  • 20. Conclusions 2 ā€¢ These physiological stress sentinel functions of dermal Vd1 T cells can become pathological by inducing IP collapse & promoting AA AA response pattern
  • 21. Youhei Uchida Marta Bertolini Jennifer Gherardini JĆ©rĆ©my ChĆ©ret et al. Special thanks to: Amos Gilhar, Haifa Alfredo Rossi, Rome Acknowledgements gd TC study Kagoshima Univ Japan Jeremy Jen
  • 22. ā€¢ Therapeutically, protecting & restoring HF IP is crucial & has the widest success chance among AA therapies ļƒ  works in all AA pathobiology scenarios, but is not curative ā€¢ Antagonizing IFNg/JAK signalling makes perfect sense, but is not the only sensible strategy & is also not curative ā€¢ Identifying the elusive CD8+/MHC class I-presented (auto-) antigens in AA and restoring peripheral tolerance remains critical for curative AA therapy ā€¢ Yet, this strategy will counteract only one of several IP collapse pathways leading to the AA response pattern ļƒ  understand roles of Tregs, NKTregs, chemokines, AIRE in human AA ļƒ target also mast cells, NK cells, excessive gdTCs activities ļƒ restore IP guardians (aMSH, VIP, CGRP; antagonize SP) Multimodal AA therapy needed !
  • 23.
  • 24. T cell "induced-self" MHC class I/peptide complexes may enable "de novo" tolerance induction to neo-antigens outside of the thymus Oelert T, Gilhar A, Paus R. Exp Dermatol. 2016 Oct [Epub ahead of print] HF epithelium can present self-antigens to cognate CD8+ T cells, incl. hair cycle-dependent immunogenic proteins including HF-specific neo-antigens. HYPOTHESIS: IFNg derived from antigen-specific T cells spotting self-peptides may induce & alter self-antigen presentation ("induced-self"). Initially, this silences autoreactive T cells, including neo-epitope-specific T cells. Since the thymus cannot recapitulate neo-epitopes evolving in the periphery, HF-specific induction of MHC molecules that present these neo-epitopes to self-peptide-reactive CD8+ T cells is a key element of self-tolerance. Subsequently, however, the local perpetuation and modification of this crosstalk induces HF IP collapse and AA ļƒ  complements thymus-based regulation models of self/non-self-discrimination: ļƒ  "induced-self" in HF maintains peripheral self-tolerance in the case of "danger" ļƒ  Can backfire, leading to AA